Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LRG-002 for Prophylaxis of Antibiotic-Associated Diarrhea
NCT04321460Phase 3Completed
- Sponsor
- Sandoz
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in antibiotic-associated diarrhea (AAD) comparing LRG-002 with Placebo (2 arms). Primary endpoints: Number of Participants With the Occurrence of Antibiotic-associated Diarrhea (AAD) - Per Protocol (PP) Population at 14 days and Number of Participants With the Occurrence of Antibiotic-associated Diarrhea (AAD) - Intention to Treat (ITT) Population at 14 days. Started Oct 2020; status: completed.
02
Drugs
LRG-002
03
Conditions
antibiotic-associated diarrhea (AAD)
Beyond the preview
Go deeper on NCT04321460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04321460.